Anti-TNF Therapy Linked to Higher Survival in Crohn’s Patients, Study Reports

Anti-TNF Therapy Linked to Higher Survival in Crohn’s Patients, Study Reports
Anti-TNF therapy is associated with lower mortality rates compared to prolonged corticosteroid use in patients with Crohn's disease, researchers suggest. This reduced mortality may be linked to lower rates of major cardiovascular events or hip fractures. Also, the lower mortality rates seen in Crohn's patients were more significant in those with multiple or serious comorbidities. A comorbidity is one or more diseases that are happening at the same time as the primary condition — in this case, Crohn's disease. As the authors suggest, these patients are often excluded from clinical trials, yet they might benefit the most from anti-TNF therapy. "This population, which is rarely included in clinical trials and for whom some phys
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *